Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

Kailera jumped the weight loss miracle-drug line by licensing four clinical-stage obesity therapies from China, which is ...

A diverse range of medical specialists offer unique expertise for obesity treatment. “Endocrinologists, bariatricians, obesity specialists and psychiatrists can prescribe weight loss medication,” ...

They say you shouldn't put personal stories on LinkedIn so I'll spare you the shirtless pics, but allow me to share something deeply personal, my journey with Zepbound. As I hit the one-year mark ...

Employers face rising GLP-1 demand. Here are tips to manage costs while maintaining care access.

Eli Lilly shares are now positive for the year, up 10% since the start of January.

Eli Lilly's experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood sugar in a trial of ...

The state’s largest commercial health insurer will stop covering a popular class of prescription drugs for weight loss, ...

Novo Nordisk, the maker of Ozempic and Wegovy, has also jumped into the legal fight —this time by intervening in the OFA’s lawsuit against the FDA. The company supports the agency’s move to restrict ...

If that doesn’t work, up the intervention ... injectable weight-loss medications, Ozempic and Wegovy. There are different GLP-1 molecules. But emerging data suggest semaglutide, the active ...

Danish drugmaker Novo Nordisk said on Monday several hundred counterfeit units of its diabetes drug Ozempic were being ...